OBJECTIVES: For a moderately dilated ascending aorta (diameter 35-54 mm), current guidelines recommend continuous annual or semiannual examinations with computed tomography or magnetic resonance imaging. However, few data have shown the yield and benefit of such a protocol. This study aimed to investigate the fate of a moderately dilated ascending aorta and thereby determine the adequate imaging interval.
INTRODUCTION
Aneurysm of the ascending aorta is a well-known risk factor for acute type A dissection. With the increasing literature and debates regarding the ascending aortic aneurysm associated with bicuspid aortic valve [1, 2] , clinicians tend to pay more attention to dilatation of the ascending aorta even before its size reaches the conventionally recommended threshold for surgical intervention. However, limited information has been established concerning the optimal medical management and surveillance protocol for a moderately dilated ascending aorta [3] .
Over the past decade, some guidelines have been published regarding the thoracic aortic aneurysm [4] [5] [6] [7] [8] . Despite their extensive coverage of almost all issues associated with diseases of the thoracic aorta, only 2 guidelines have remarked on the follow-up surveillance of a thoracic aortic aneurysm which is less than the recommended criteria for intervention. In these 2 guidelines [7, 8] , a continuous annual or semi-annual examinations with computed tomography (CT) or magnetic resonance (MR) imaging is proposed for patients who have a maximal ascending aortic diameter between 35 and 55 mm. However, their reference lists do not contain literature substantiating such a proposal. Our own literature search using PubMed found only 1 article specifically dealing with this issue [9] . So, this study investigated the fate of a moderately dilated ascending aorta with the aim to determine the adequate interval of follow-up imaging examinations.
METHODS
Our institution has a large database called the clinical data warehouse (CDW), which contains all numerical and text data obtained from laboratory tests and imaging examinations of every patient since the opening of the hospital in 2003. From the CDW, we identified 181 408 contrast-enhanced CT examinations which were performed between June 2003 and September 2014 and visualized the thoracic aorta in patients 16 years or older. Providing the entire thoracic aorta was included in the scan, all examinations performed by various protocols were included. Among them, 28 032 patients were found to have undergone two or more such CT examinations and in 17 755 patients the interval between the first and last CT scans was 12 months or longer. Then, the patients were filtered to identify those whose CT report by radiologists included the words 'ascending aorta' AND ['dilatation' OR 'aneurysm']. For the 1271 patients identified, the first CT scan images were reviewed by a single investigator (KHP) to measure the maximal diameter of the ascending aorta. Only the tubular portion of the ascending aorta was inspected and the size of the aortic root was not considered. Finally, a total of 509 patients (n = 284 males, 55.8%; n = 225 females, 44.2%) were enrolled into this study including only those who had a 40 mm or larger ascending aorta and excluding those who had Marfan syndrome and other connective tissue diseases, or acute aortic syndrome (type A dissection, intramural haematoma, penetrating atherosclerotic ulcer) at the initial scan, or elective replacement of the ascending aorta before the second CT scan. The mean age of the patients was 67.2 ± 10.4 years (range 35-93 years). The mean interval between the first and last CT scans was 4.3 ± 2.4 years (range 1-11.4 years)
The primary endpoint investigated was a significant progression of the ascending aortic aneurysm defined as a 5-mm or larger growth regardless of the interval. The incidence of significant progression was determined by comparing the maximal diameter of the ascending aorta in each patient between the first and last CT scan. Review of images and measurements in all patients were done by a single investigator. After identifying the transverse axial slice showing the largest diameter of the ascending aorta in the first CT scan, the diameter was compared with the last CT scan at the same level. The internal diameter (the lumen enhanced by the contrast agent) was measured along the line parallel to the long axis of the right pulmonary artery (Fig. 1) . The mean growth rate of the ascending aortic aneurysm was calculated by dividing the diameter difference by the CT interval. For 47 patients who showed a negative change in the maximal diameter, such values were censored and replaced with 0.
The electronic medical records of all patients were reviewed to investigate the associated illness and the following secondary end-points: rupture, aortic dissection or intramural haematoma (IMH) involving the ascending aorta and elective ascending aorta replacement. The last contact documented by any doctor at our institution was regarded as the final follow-up. The mean duration of clinical follow-up between the time of the first CT scan and the last contact was 5.6 ± 2.6 years (range 1-12.2 years). The survival of all patients was checked by inquiring of the Ministry of Security and Public Administration of our national government. The difference in the incidence of end-points, according to the initial size of the ascending aorta, was statistically analysed, and the clinical variables associated with the primary endpoint of significant progression were investigated. 
RESULTS
In the overall patients, the mean and median growth rates of the ascending aorta were 0.3 ± 0.5 and 0 mm/year, respectively. The ascending aorta dilated by 5 mm or more in 29 patients (5.7%). Table 1 shows the fate of the ascending aortic aneurysm and the difference according to the initial size. The growth rate of the ascending aorta having a 40-50 mm initial diameter (mean 0.3 mm/year and median 0 mm/year) was significantly lower than that of larger ones. The incidence of significant progression was also significantly lower for a 40-50 mm ascending aorta and did not exceed 6%. The Kaplan-Meier curves for freedom from significant progression showed that these patients had a more than 95% freedom rate at 5 years ( Fig. 2 ). Comparing the patients who had an initial diameter of 40-44 and 45-49 mm, respectively, there was no difference in the aneurysm growth rate or the incidence of primary and secondary end-points. In 0.6% (3/463) of the patients belonging to these groups, the size of the ascending aorta reached 55 mm during the mean interval of 4.3 ± 2.5 years. All these patients subsequently underwent elective ascending aorta replacement.
Acute type A dissection or IMH occurred in 5 patients; dissection in 4 and IMH in 1. The initial maximal diameter of the ascending aorta in these 5 patients was 40, 46, 48, 50 and 52 mm, respectively. None of them had a bicuspid aortic valve or disproportionately enlarged aortic root. By the time dissection occurred, none of these patients had a significant interval change or dilatation up to 55 mm; the final maximal diameter was 42 (3 years after the first CT), 49 (6.1 years), 48 (10.1 years), 53 (3.6 years) and 52 mm (1.7 years), respectively. Elective ascending aorta replacement was performed in 10 patients (2.0%) after the last CT scan. Six of these patients required surgery due to aneurysm progression. In the remaining 4 patients, the ascending aorta was replaced concomitantly with aortic valve replacement or coronary bypass grafting, despite showing no interval change in the ascending aortic diameter. Inquiry to the national government revealed that 121 patients had died by 1 August 2016. The cause of death could be identified in 92 of them who died during or shortly after hospitalization at our hospital. Among them, there was no death attributable to the ascending aortic aneurysm. The most common cause of death was malignancy (47 patients) and other causes included cerebrovascular accident (20), respiratory failure (12), infection (5), cardiac diseases (5), and complications of major surgery (3).
Echocardiography was done in 417 patients including the 29 patients who showed a significant progression of the ascending aortic aneurysm. Bicuspid aortic valve was documented in 27 patients (27/417 = 6.5%). A significant progression of the ascending aortic aneurysm occurred in 11.1% (3/27) of the patients who had a bicuspid aortic valve and in 6.4% (25/390) of the patients with a tricuspid aortic valve. For those who did not undergo echocardiographic examination, the incidence was 1.1% (1/92). The difference was significant by univariate but not multivariate analysis. Likewise, in the instance of malignancy which was found more frequently in the patients not showing progression of an ascending aortic aneurysm. In 87 patients (17.1%), acute aortic syndrome or aneurysm of other segments of the aorta was diagnosed prior to the first CT scan or during the observed period. Sixty-six of these patients underwent surgical or endovascular repair; arch in 3, descending thoracic aorta in 14, thoracoabdominal aorta in 18, and abdominal aorta in 37. The presence of such history or lesions was not significantly associated with progression of the ascending aortic aneurysm. In multivariate analysis, aortic valve regurgitation and initial ascending aortic diameter were the only significant risk factors for significant progression (Table 2) .
DISCUSSION
The emerging interest in an ascending aortic aneurysm is mainly focused on that associated with the bicuspid aortic valve or aortic valve stenosis [1, 2] . However, it is not a rare condition even in individuals with a normal tricuspid aortic valve. With an aging population and the widespread availability of advanced imaging 
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modalities, an increasing number of patients are presenting with dilatation of the ascending aorta [9] . Based on the process of enrolment of the patients into the present study, the prevalence of an ascending aortic dilatation > _40 mm is estimated to be around 3% in our institution, which is a tertiary referral center located in a residential town of a metropolitan city. The relatively high prevalence of this condition is attributed to the aged population of the region, reflected by the higher mean age of our patients compared to previous reports. In contrast to the abundance of data regarding the surgical and endovascular techniques to treat aortic diseases, the dearth of information on the natural history of an ascending aortic aneurysm has not been satisfactorily resolved [10] . While current guidelines recommend surgical replacement of an ascending aortic aneurysm exceeding 55 mm maximum diameter for patients who have a normal aortic valve and no symptoms [4] [5] [6] [7] [8] , such a generally accepted recommendation lacks a high level of evidence. The well-known report from the Elefteriades' group at Yale University [11] and their continuing studies are the only major evidence listed in the reference of current guidelines. As for the medical treatment and follow-up surveillance of a thoracic aneurysm smaller than a surgical indication, the paucity of evidence is more serious [3] . Only 2 of the current guidelines have remarks regarding these issues and propose continuous annual or semi-annual CT/MR examinations for an ascending aorta with a diameter between 35 and 55 mm [7, 8] . Applying the guidelines to patients in their 50s would force them to undergo at least 20 CT or MR examinations during their subsequent lifetime. We assumed that such a frequent follow-up protocol may be too aggressive and inefficient, considering the expense, radiation hazard associated with CT, and most importantly, the slow growth rate of an ascending aortic aneurysm.
It is known that the growth of an aortic aneurysm is slower in the instance of a small aneurysm and in the ascending aorta compared to a larger aneurysm and the descending aorta [11, 12] . The Yale group reported a mean growth rate of 0.7-0.8 mm/ year (95% CI 0.3-1.2) for an ascending aorta having an initial diameter of 40-49 mm and 1 mm/year (95% CI 0.4-1.5) for an aneurysm larger than 50 mm. While the Yale group investigated a relatively large number of patients enrolled in a well-maintained database and used a sophisticated formula to calculate the aortic growth rate, their studies are considered to have some limitations. The actual number of patients belonging to the subgroup having a 40-50 mm ascending aorta did not exceed 100, for whom the median imaging interval was only 19 months and included a substantial number of patients with chronic dissection.
The growth rate reported by the Yale group was already significantly lower than what had been reported previously [13, 14] . In addition, our results, which show an even lower growth rate (0.3-0.6 mm/year), suggest that moderate dilatation of the ascending aorta progresses much more slowly than what has previously been believed. This is supported by the recently published report from Canada, which was similar to our research in reference to the aim, cohort size, patients' age, and duration of follow-up [9] . The difference between the Canadian study and ours is that they included an aortic root aneurysm and annuloaortic ectasia (25.1%) and had a much higher prevalence of bicuspid aortic valve (21.5%). Despite such a difference, they reported a similar growth rate as ours (0.4 mm/year) for an ascending aorta having a 40-50 mm diameter and, interestingly, it was slightly lower for a 46-50 mm aneurysm than 40 -45 mm aneurysm.
In the Yale data, which analysed the thoracic aorta as a whole, the summated yearly rate of rupture and dissection of a 40-49 mm aneurysm was 2% [12] . Applying this estimate to our study cohort, we would have seen more than 50 cases of acute dissection or rupture. However, the actual incidence of acute type A Note that data were available on the following subsets of patients: ascending aorta diameter increase <5 mm, n = 388; ascending aorta diameter increase > _ 5 mm, n = 29.
c Include dissection, intramural haematoma, penetrating ulcer and degenerative aneurysm involving any location other than the ascending aorta.
dissection and IMH in our result was only 1% during the mean follow-up of 5.6 years. This is identical to the data from the Massachusetts General Hospital; 1% incidence during a median follow-up of 40 months for 628 patients having a 40-mm or larger ascending aorta (mean diameter 47 mm) [15] . In the Canadian study, where all patients were under tight blood pressure control at a dedicated aortic clinic, there was only 1 case of IMH among 251 patients during a mean 4.3-year follow-up [9] . Compared with the very low incidence of acute dissection in the general population, the incidences shown by these 3 studies, including ours, may not be low enough to conclude that moderate dilatation of the ascending aorta is a benign condition. We also cannot deny that interval expansion of a moderate size aneurysm may be a significant risk factor for rupture or dissection. However, none of the 5 acute type A dissections in our study was preceded by > _5 mm growth of the ascending aorta or progression to the threshold for elective surgery. So, with the lack of other markers predicting and stratifying the susceptibility to dissection or rupture, we doubt that relying solely on frequent imaging surveillance for interval growth is a sensitive and cost-effective measure for predicting or preventing such life-threatening events.
The slow growth of a moderate ascending aortic aneurysm led to a very high rate of long-term freedom from definite and significant progression, defined as dilatation by 5 mm or more. None of the 40-50 mm ascending aortic aneurysms showed significant progression at 2 years and more than 95% remained stable after 5 years. The incidence of an acute aortic event and a need for elective surgery was also low. These results are in line with other recent studies [9, 15] , although Gagne-Loranger et al.
[9] reported a higher incidence of elective surgery probably due to including more patients with a bicuspid aortic valve or annulo-aortic ectasia. Considering the similarity and difference between the Canadian study and ours, we agree that the interval between imaging follow-ups may be extended. However, in contrast to their cautious suggestion of extending the interval to 18-24 months, we consider a 3-to 4-year interval to be more costeffective, without increasing the patient's risk of an adverse outcome.
The present study has some limitations. First, it may be argued that the aortic diameter measurement could be inaccurate in some instances, as the protocol and equipment for CT scan varied among the patients. Although such a factor may lead to some inaccuracy in calculating the growth rate, we do not believe that it affected the identification of a significant interval progression, defined as 5 mm or larger growth. Second, inaccuracy in calculating the growth rate may also result from our simple formula and censoring the negative interval differences and replacing them with 0. It is known that such limitations tend to overestimate the growth rate [16] , and they would not weaken our suggestion but rather support the slow growth of the ascending aortic aneurysm. The third limitation is that our patients comprised a very heterogeneous population and only a very limited number of them were followed up by aortic or cardiovascular specialists. Also, only their major illnesses were investigated for data collection without paying attention to the presence of hypertension or tobacco smoking because the institutional database (CDW) included only the results of laboratory and imaging examinations. If we had tried to investigate such clinical parameters which are possibly associated with the risk of aneurysm expansion or dissection, it would have required an extensive and more thorough review of all medical records, which we could not afford at the time of this study. As the height and weight were also missing in the CDW and some medical records, we could not calculate the indexed size of the ascending aorta in all patients and the data had to be analysed on the basis of absolute diameters. Echocardiography was not performed in a substantial number of patients. In the majority of the patients, the timing of echocardiography did not coincide with the initial CT, as we included all echocardiographic data regardless of the time of examination. While these factors may undervalue our analysis of risk factors associated with aneurysm progression, we do not believe they affect the major finding of our results. Lastly, the patients with aortic root aneurysm were not accounted for in our study and the majority of our patients were older than 60 years. Considering that the growth rate of a dilated aorta may differ according to age and younger patients may be prone to faster growth, it may be doubted whether the same extension of imaging interval can be recommended for the patients in their 40s or 50s. The same argument applies to the patients with an aortic root aneurysm, bicuspid aortic valve, or aortic valve regurgitation. As our data showed that bicuspid valve and significant aortic valve regurgitation were associated with higher incidence of progression of an ascending aortic aneurysm, a shorter imaging interval may be required. However, the number of patients (less than 30) belonging to those subsets was not large enough to give a definite answer to the question whether they still require a follow-up imaging at least once a year, which we believe is too much even for them. Future studies on a larger cohort would resolve this query.
In conclusion, the growth of a moderately dilated ascending aorta is too slow to justify annual or semi-annual imaging followup of all patients who have this condition, as recommended in the current guidelines. Frequent surveillance for interval growth is not considered sensitive or cost-effective for predicting an aortic dissection. So, a 3-to 4-year interval would be reasonable as a general guideline for subsequent CT or MR examinations for a moderately dilated ascending aorta not initially exceeding 45 mm and remaining stable in the first annual follow-up imaging. Future studies are warranted to identify those who have a higher potential for faster aneurysm expansion and increased risk of dissection justifying a shorter imaging interval.
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